Reference is made to the stock exchange notice from Vistin Pharma ASA earlier today, 22 March 2018, regarding a subsequent repair issue of approximately NOK 50 million. Key information for the subsequent repair issue is described below.
Date on which the terms and conditions of the subsequent repair issue were announced: 22 March 2018
Last day including right: 22 March 2018
Ex-date: 23 March 2018
Record Date: 26 March 2018
Date of approval: 9 May 2018
Maximum number of new shares: 4,464,286
Subscription price: NOK 11.20
Will the rights be listed - yes/no: No
Other information: The subsequent repair issue is subject to approval by the annual general meeting of Vistin Pharma ASA and approval and publication of a prospectus, expected to take place on or about 11 May 2018.
This information is published in accordance with the requirements of the Continuing Obligations.